Dot Medical signed a Joint Distribution agreement with Cardiogenics on Tuesday (19th October 2010) to sell the QuikClot Interventional Hemostatic Bandage manufactured by Z-Medica Inc. The QuikClot Interventional obtains prompt hemostasis and allows an early and safe ambulation following coronary diagnostic and interventional procedures by femoral approach.

The QuikClot works fast, requiring only 5 minutes of firm manual compression above the puncture site after removal of the arterial sheaths. With a proven efficacy of 99%, the US military has chosen QuikClot as their exclusive choice to stem extreme bleeding in wartime injuries. The active ingredient (Kaolin) has no human or animal derived proteins, no thrombin or fibrinogen, or shellfish byproducts and has been recognized as an effective clotting agent for more than 50 years. in addition there are no contra-indications to its use and is completely non-invasive. Ian Rankin, Managing Director of Dot Medical said, "We are delighted to be signing this agreement to bring this really innovative product to our UK physicians. the price is extremely reasonable and substantially less than any mechanical closure device currently on the market". Director of Cardiogenics, Paul Hannigan said " The QuikClot is amazing and wil quicken procedures, reduce infection, and save money too. We are very happy to be partnering Dot Medical in this venture". QuikClot is immediately available from Dot Medical for hospitals in England, Scotland and Wales. Hospitals in Northern ireland and Republic of Ireland can purchase QuikClot from Cardiogenics Ltd. To arrange a demonstration or to order QuikClot call the following numbers:

Dot Medical +44 1625 668811 (for hospitals in England, Scotland and Wales)
Cardiogenics +353 87231 3210 (for hospitals in Nortern Ireland and Republic of Ireland)

For further information on QuikClot click here

For other news about Dot Medical click here